Phillip A. Sharp Ph.D.
|Age||Total Calculated Compensation||This person is connected to 174 board members in 10 different organizations across 9 different industries.|
See Board Relationships
Dr. Phillip A. Sharp, also known as Phil, Ph.D., Co-Founded Alnylam Pharmaceuticals, Inc. in 2002. Dr. Sharp serves as the President of American Association for the Advancement of Science. He Co-founded Biogen Idec Inc. in 1978. He co-founded Magen BioSciences, Inc. (now known as PPD Dermatology, Inc.) in 2006. He serves as the Chairman of Scientific Advisory Board of Fidelity Biosciences. He served as Co-Chairman of Scientific Strategy and Advisory Group of Alnylam ...
1200 New York Avenue NWPhone: 202-326-6400
Washington, District Of Columbia 20005
Board Members Memberships*
Director and Member of Strategic Advisory Board
Co-Founder, Director and Member of the Scientific Advisory Board
Director, Member of Scientific Advisory Board and Chairman of Compensation Committee
University of Illinois-Urbana-Champaign
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer and President|
Ionis Pharmaceuticals, Inc.
|Edward M. Kaye M.D., Ph.D.||Chief Executive Officer, President, Chief Medical Officer and Director|
Sarepta Therapeutics, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Executive Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$490.0K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.